Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)

NCT05197881 is registered in ClinicalTrials.gov with Varian, a Siemens Healthineers Company as lead sponsor.

NCT NCT05197881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05197881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)
Lead sponsor
Varian, a Siemens Healthineers Company
Phase
Not applicable
Overall status
Recruiting
Start date
May 3, 2022
Completion date
September 30, 2030
Enrollment
125 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer by figo stage 2018